Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Blended Treatment for Alcohol Use Disorder

NCT: NCT04535258 · ACTIVE_NOT_RECRUITING

NCT IDNCT04535258
StatusACTIVE_NOT_RECRUITING
Start Date2020-06-01
Completion2027-12-31

Brief Summary

Blended Treatment for Alcohol Use Disorder (BLEND-A) is a pragmatic, cluster randomized controlled trial to assess the clinical effectiveness and cost-effectiveness of implementing a blended treatment format that aims to reduce problematic alcohol use. Blended treatment is a treatment format where treatment as usual is offered as a combination of online and face-to-face sessions, integrated into one treatment protocol. The BLEND-A study will evaluate and implement a blended treatment program in routine alcohol addiction treatment. The trial is led by Unit of Clinical Alcohol Research, University of Southern Denmark (UCAR) in collaboration with partners at the Centre for Telepsychiatry in the Region of Southern Denmark (CTP), and Sundhed.dk.

Frequently Asked Questions

What is Blended Treatment for Alcohol Use Disorder?

Blended Treatment for Alcohol Use Disorder is a clinical trial registered under NCT04535258. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04535258?

The current status of NCT04535258 (Blended Treatment for Alcohol Use Disorder) is: ACTIVE_NOT_RECRUITING.

When did Blended Treatment for Alcohol Use Disorder start?

Blended Treatment for Alcohol Use Disorder started on 2020-06-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.